Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
99%
Myocardial Infarction
34%
Left Ventricular Function
32%
Cardiomyocytes
32%
Inflammation
26%
Cardiac Function
21%
Pressure Overload
19%
Ischemic Heart Failure
17%
Failing Heart
17%
Post-myocardial Infarction
16%
Cardiovascular Disease
16%
Heart Failure with Preserved Ejection Fraction (HFpEF)
16%
Left Ventricular Remodeling
16%
Interleukin-18 (IL-18)
15%
Apoptosis
14%
O-linked N-acetylglucosamine (O-GlcNAc)
14%
Cardiac Hypertrophy
14%
Adverse Cardiac Remodeling
14%
Hypertrophy
14%
Myocardium
13%
Cardiac Remodeling
13%
Estimated Glomerular Filtration Rate
13%
Nitric Oxide
13%
Cardioprotection
12%
Inducible Nitric Oxide Synthase
12%
Myocytes
12%
Cardiomyopathy
12%
Cell Culture Model
12%
Medicare Beneficiaries
12%
Endothelial Cell Culture
12%
Tumor Necrosis Factor-α
12%
Macrophages
12%
Interleukin-1β
12%
95% Confidence Interval
11%
Fibrosis
11%
Nuclear factor-B
10%
Hazard Ratio
10%
Left Ventricle
10%
Left Ventricular Dysfunction
10%
Calves
10%
CD4+ T
10%
AKT1
10%
Cardiac Dysfunction
10%
Oxidative Stress
10%
Pathological Remodeling
10%
Heme oxygenase-1 (HO-1)
10%
NF-B
10%
Adrenergic Receptors
9%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
9%
Ischemia-reperfusion Injury
9%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Ventricle Remodeling
36%
Heart Infarction
34%
Inflammation
27%
Infarction
19%
Acrolein
16%
Calcium Ion
14%
Myocardial Disease
13%
Nitric Oxide
13%
Cytokine
13%
Aldehyde
12%
Heart Muscle Ischemia
10%
Alternative Complement Pathway C3 C5 Convertase
10%
Nuclear Factor
10%
Adrenergic Receptor
10%
Aortic Constriction
10%
Fibrosis
10%
Arachidonate 15 Lipoxygenase
9%
Heme Oxygenase 1
9%
Interleukin 1
8%
Heart Left Ventricle Failure
8%
Tumor Necrosis Factor
8%
All Cause Mortality
7%
Cardiotoxicity
7%
Congestive Cardiomyopathy
7%
Angiotensin II
7%
Cardiovascular Disease
7%
Diseases
7%
Doxorubicin
7%
Hypertension
7%
Heart Ventricle Hypertrophy
7%
Heart Muscle Fibrosis
6%
Systolic Heart Failure
6%
Messenger RNA
6%
Wild Type Mouse
6%
Cerebrovascular Accident
6%
Rat
6%
Isoprenaline
6%
Glutathione
6%
Reperfusion Injury
6%
Transferase
6%
Ischemic Cardiomyopathy
6%
Tumor Necrosis Factor Receptor
6%
Interleukin 18
6%
Oxidoreductase
6%
Nicotinamide Adenine Dinucleotide Phosphate
6%
Ticagrelor
6%
Acute Coronary Syndrome
6%
Eptifibatide
6%
Beta Adrenergic Receptor Blocking Agent
6%
Medicine and Dentistry
Congestive Heart Failure
61%
Hemodynamic
25%
Heart Function
24%
Inflammation
22%
Cardiovascular Disease
17%
Heart Ventricle Remodeling
16%
Cardiac Muscle Cell
16%
Heart Muscle Ischemia
14%
Cell Culture
13%
Myocardial Infarction
13%
Ventricular Assist Device
12%
In Vitro
11%
Endothelial Cell
11%
Infarction
11%
Coronary Artery Disease
10%
Heart Failure with Preserved Ejection Fraction
9%
Left Ventricle
9%
Counterpulsation
9%
Leukocyte
8%
Heart Left Ventricle Function
8%
Myocardial Disease
8%
Left Ventricular Assist Device
7%
Apoplexy
7%
Cardiac Fibrosis
7%
Calcium Ion
7%
Fibrosis
7%
Echocardiography
7%
Myocardium
7%
Nitric Oxide
7%
Programmed Cell Death
7%
Macrophage
7%
Interleukin 1
6%
Monocyte
6%
Aortic Constriction
6%
Cardiovascular Risk
6%
Cardiovascular Mortality
6%
Ischemic Cardiomyopathy
6%
Meta-Analysis
6%
Beta Adrenergic Receptor Blocking Agent
6%
Systolic Heart Failure
6%
Heart Graft
6%
Ryanodine
6%
Inotropism
6%
Cardiac Pathology
6%
Coronary Circulation
6%
Tachyarrhythmia
6%
Clinical Trial
5%
Heart Left Ventricle Failure
5%
Cardiovascular System
5%
Chronic Kidney Disease
5%